Clinical trial
Systemic Vascular Dysfunction in COPD Patients With Mild-to-moderate Airflow Obstruction: Pharmacological Treatment With N-acetylcysteine
NCT02579772 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Systemic Vascular Dysfunction in COPD Patients With Mild-to-moderate Airflow Obstruction: Pharmacological Treatment With N-acetylcysteine
- Lead sponsor
- Queen's University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- May 31, 2016
- Enrollment
- 13 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.